These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35534883)

  • 41. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis (ABC trial): study protocol for a pragmatic randomized controlled trial.
    Ragamin A; Fieten KB; Tupker RA; de Wit J; van Mierlo MMF; Jansen MS; Bronner MB; Schappin R; Schuren FHJ; Romeijn MLE; Arents BWM; Polinder S; de Graaf M; Rustemeyer T; Schuttelaar MLA; Pasmans SGMA
    Trials; 2021 Dec; 22(1):902. PubMed ID: 34895292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
    Paller AS; Flohr C; Cork M; Bewley A; Blauvelt A; Hong HC; Imafuku S; Schuttelaar MLA; Simpson EL; Soong W; Arlert P; Lophaven KW; Kurbasic A; Soldbro L; Vest NS; Wollenberg A
    JAMA Dermatol; 2023 Jun; 159(6):596-605. PubMed ID: 37074705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
    King B; Maari C; Lain E; Silverberg JI; Issa M; Holzwarth K; Brinker D; Cardillo T; Nunes FP; Simpson EL
    Am J Clin Dermatol; 2021 May; 22(3):395-405. PubMed ID: 33826132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Paller AS; Simpson EL; Siegfried EC; Cork MJ; Wollenberg A; Arkwright PD; Soong W; Gonzalez ME; Schneider LC; Sidbury R; Lockshin B; Meltzer S; Wang Z; Mannent LP; Amin N; Sun Y; Laws E; Akinlade B; Dillon M; Kosloski MP; Kamal MA; Dubost-Brama A; Patel N; Weinreich DM; Yancopoulos GD; O'Malley JT; Bansal A;
    Lancet; 2022 Sep; 400(10356):908-919. PubMed ID: 36116481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety, effectiveness, and economic evaluation of an herbal medicine, Ukgansangajinpibanha granule, in children with autism spectrum disorder: a study protocol for a prospective, multicenter, randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Lee SH; Shin S; Kim TH; Kim SM; Do TY; Park S; Lee B; Shin HJ; Lee J; Lee JY; Chang GT
    Trials; 2019 Jul; 20(1):434. PubMed ID: 31307524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
    Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
    Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chinese herbal medicine for atopic dermatitis: a systematic review.
    Tan HY; Zhang AL; Chen D; Xue CC; Lenon GB
    J Am Acad Dermatol; 2013 Aug; 69(2):295-304. PubMed ID: 23759835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study.
    Eichenfield LF; Gower RG; Xu J; Alam MS; Su JC; Myers DE; Sanders P; Vlahos B; Zang C; Lan J; Werth J
    Am J Clin Dermatol; 2023 Jul; 24(4):623-635. PubMed ID: 37184828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trial.
    Zhang X; Cheng Y; Li X; Tan X; Shi L; Shi X; Zhang X; Xie C; Li J
    Trials; 2021 Aug; 22(1):545. PubMed ID: 34407832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial.
    Wang Q; Li Z; Guo J; Li W; You F
    PLoS One; 2022; 17(12):e0275058. PubMed ID: 36525406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
    Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
    Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of the Chaihuguizhiganjiang-suanzaoren granule on primary insomnia: study protocol for a randomised controlled trial.
    Liu QQ; Zhang J; Guo RJ; Xie YZ; Fu QN; He T; Zhu XQ; Du J; Yang J; Wang JL; Wei MM; Li QQ; Shi GX; Liu CZ
    BMJ Open; 2016 Feb; 6(2):e008459. PubMed ID: 26839010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, double-blind, placebo-controlled trial for Yi-Qi Hua-Yu tong-sui granule in the treatment of mild or moderate cervical spondylotic myelopathy.
    Xu C; Zhou X; Tong Z; Ma J; Ye J; Xu J; Mo W
    Medicine (Baltimore); 2020 Aug; 99(33):e21776. PubMed ID: 32872078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pilot study exploring the efficacy and safety of herbal medicine on Korean obese women with metabolic syndrome risk factors: Double blinded, randomized, multicenter, placebo controlled study protocol clinical trial.
    Kim HJ; Ko Y; Kim H; Cha YY; Jang BH; Song YK; Ko SG
    Medicine (Baltimore); 2020 Jan; 99(5):e18955. PubMed ID: 32000419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing high altitude treatment with current best care in Dutch children with moderate to severe atopic dermatitis (and asthma): study protocol for a pragmatic randomized controlled trial (DAVOS trial).
    Fieten KB; Zijlstra WT; van Os-Medendorp H; Meijer Y; Venema MU; Rijssenbeek-Nouwens L; l'Hoir MP; Bruijnzeel-Koomen CA; Pasmans SG
    Trials; 2014 Mar; 15():94. PubMed ID: 24670079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herbal Medicine
    Lee B; Park HJ; Jung SY; Kwon OJ; Park YC; Yang C
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.